The global cell and gene therapy supply chain software market was valued at USD 1.62 Billion in 2025, driven by the increasing prevalence of genetic disorders, cancer, and other chronic conditions across the globe. The market is anticipated to grow at a CAGR of 11.20% during the forecast period of 2026-2035, with the values likely to reach USD 4.68 Billion by 2035.
Base Year
Historical Period
Forecast Period
The market is poised for significant growth as the demand for efficient, data-driven logistics and real-time monitoring increases in response to complex biomanufacturing processes.
Rising regulatory complexities and the need for greater transparency in gene therapy manufacturing are driving the adoption of supply chain software solutions, fostering improved compliance and risk management.
With the expansion of personalised medicine and biopharmaceutical innovations, the market for cell and gene therapy supply chain software is expected to witness substantial investment in automation and AI-driven technologies for optimised operations.
Cell and gene therapy supply chain software is designed to optimise the logistics, storage, and distribution of biological products. It addresses the unique challenges of managing temperature-sensitive therapies, ensuring regulatory compliance, and tracking product integrity throughout the supply chain. This software enhances efficiency, transparency, and security, supporting the growth and scalability of the cell and gene therapy industry.
Strategic Collaborations to Boost Market Growth
The increasing demand for efficient manufacturing solutions and advancements in data analytics are key drivers for market growth. In April 2024, Autolomous, a leader in manufacturing management systems, partnered with BioCentriq, a clinical-phase Cell Therapy CDMO. Their collaboration aims to revolutionise the process development and manufacturing of cell and gene therapies through Autolomous' innovative autoloMATE® platform. This fully cloud-native, no-code software is designed to improve data capture, operational logistics, and tech transfer. It will empower BioCentriq to optimise efficiency while ensuring top-tier quality and data integrity, significantly enhancing the capabilities of the cell and gene therapy sector. This partnership is poised to positively influence the market's growth in the forecast period, driving demand for advanced software solutions in process development and manufacturing.
Emphasis on Expertise and Precision to Foster Cell and Gene Therapy Supply Chain Software Market Demand
The rising complexity of clinical trials and regulatory requirements in the cell and gene therapy sector are driving the need for specialised supply chain software solutions. For instance, in January 2024, TrakCel, a recognised leader in cellular orchestration systems, launched its Consultancy Services aimed at providing valuable expertise to CGT developers. This service focuses on critical areas such as Chain of Identity Strategy, Data Protection Compliance, and Supply Chain Risk Assessment, addressing the unique challenges faced by therapy developers. By offering their extensive process development experience, TrakCel is poised to streamline operations, mitigate risks, and improve compliance, supporting the growth and evolution of the cell and gene therapy supply chain. This initiative will play a key role in accelerating the market’s expansion over the coming years, reinforcing the demand for expert-driven solutions in supply chain management.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Application
Market Breakup by Deployment
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on End Users to Witness Significant Growth
Pharmaceutical and biotechnology companies are likely to lead the market share based on end users, primarily due to the increasing development and commercialisation of advanced cell and gene therapies by pharmaceutical and biotechnology firms. These companies require robust software solutions to manage the complexities of gene therapy supply chains, including cold-chain logistics, regulatory compliance, and ensuring product integrity from production to delivery. The growing investment in gene therapies, particularly for rare and chronic diseases, is driving the demand for efficient, secure, and scalable supply chain solutions in this segment, giving it a dominant market share.
North America leads the market due to its robust healthcare infrastructure, high adoption of advanced technologies, and a growing number of biopharma companies focused on gene and cell therapies. The presence of key industry players, strong regulatory support, and significant investments in research and development further propel market growth. Additionally, the rising demand for personalised medicine and innovative therapies in the region strengthens North America's dominant market share.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Chelmsford, Massachusetts, Azenta Life Sciences was established in 2021. The company provides a comprehensive portfolio of integrated solutions for the cell and gene therapy supply chain, including cold-chain logistics, sample management, and automated storage systems. Azenta’s technologies are designed to ensure safe, efficient transportation and storage of biologics and gene therapy products globally.
Founded in 1987 and headquartered in the UK, Biocair specialises in providing logistics and supply chain solutions for the life sciences industry. Its portfolio includes cold-chain transportation, temperature-controlled packaging, and specialised courier services tailored to cell and gene therapies. Biocair’s global presence ensures secure, compliant handling of complex biological products, supporting the growing demand for gene therapy supply chains.
BioLife Solutions, based in Bothell, Washington, was established in 1987. The company offers advanced cell and gene therapy supply chain solutions, including cryopreservation media, controlled-rate freezers, and automated thawing systems. BioLife’s products support the safe storage, transport, and handling of biologics, particularly for cell and gene therapy applications, ensuring the preservation of critical therapies across the supply chain.
Cryoport Systems, LLC. is a leading provider of supply chain solutions for the life sciences industry, with a particular focus on temperature-controlled logistics for biological materials. Their services are crucial for industries such as cell and gene therapy, which require precise handling and transportation of sensitive materials like cells, tissues, and gene-modified products.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Lonza, NMDP BioTherapies, TraceLink Inc., LabVantage Solutions Inc., and TrakCel.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Deployment Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share